Insider Transactions in Q2 2024 at Jaguar Health, Inc. (JAGX)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 17
2024
|
Pravin R Chaturvedi Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
871
+28.92%
|
-
|
|
May 17
2024
|
Lisa A Conte CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
2,695
+26.98%
|
-
|
|
May 17
2024
|
Steven R. King |
BUY
Exercise of conversion of derivative security
|
Direct |
612
+25.84%
|
-
|
|
May 17
2024
|
Carol R. Lizak Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
431
+29.26%
|
-
|
|
May 17
2024
|
Jonathan S. Wolin |
BUY
Exercise of conversion of derivative security
|
Direct |
871
+30.21%
|
-
|
|
Apr 05
2024
|
Lisa A Conte CEO and President |
BUY
Exercise of conversion of derivative security
|
Direct |
600
+11.54%
|
-
|
|
Apr 05
2024
|
Steven R. King |
BUY
Exercise of conversion of derivative security
|
Direct |
178
+13.46%
|
-
|
|
Apr 05
2024
|
Carol R. Lizak Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
60
+8.94%
|
-
|
|
Apr 05
2024
|
Jonathan S. Wolin |
BUY
Exercise of conversion of derivative security
|
Direct |
89
+7.24%
|
-
|
|
Apr 05
2024
|
Pravin R Chaturvedi Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
134
+9.54%
|
-
|